comparemela.com

Latest Breaking News On - Paul matteis - Page 6 : comparemela.com

AbbVie to buy Cerevel in $8 7B bet on brain drugs

BioPharma

United kingdomUnited statesRon renaudPaul matteisKaruna karRichard gonzalezBiohaven pharmaceuticalsCerevel therapeuticsTranslate bioKaruna therapeutics

BioMarin secures hemophilia gene therapy coverage in Germany

BioPharma

Paul matteisItalian medicines agencyEuropean unionDive briefMarin pharmaceuticalGerman national associationStatutory health insurance fundsDrug pricingGene therapy

Stifel Starts Lexeo Therapeutics (LXEO) at Buy, Catalyst-Rich 2024

Stifel Starts Lexeo Therapeutics (LXEO) at Buy, Catalyst-Rich 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paul matteisLexeo therapeutics

BioMarin prices hemophilia gene therapy at nearly 29,000 euros per vial in Germany

BioMarin Pharmaceutical said on Tuesday it will price its therapy for severe hemophilia A at 28,933.53 euros per vial for insurers covering a majority of the population in Germany, Europe s.

United statesPooja desaiPaul matteisLeroy leoEuropean unionMarin pharmaceuticalGerman national associationStatutory health insurance funds

Market movers: Why SU-T, FM-T, TRZ-T and more stocks are seeing action on Monday

A survey of North American equities heading in both directions

United statesBritish columbiaNew zealandPaul lejuezCrown castleMarc bedardJason genrichPaul matteisDominic levasseurJesse cohnCenovus energy incFoot locker incTransat at incCanadian union of public employeesSuncor energy incVancouver xenon pharmaceuticals

vimarsana © 2020. All Rights Reserved.